Logo image
mRNA vaccination overcomes haemozoin-mediated impairment of whole-parasite malaria vaccines in mice
Journal article   Open access   Peer reviewed

mRNA vaccination overcomes haemozoin-mediated impairment of whole-parasite malaria vaccines in mice

Mariah Hassert, Lisa L. Drewry, Lecia L. Pewe, Lisa S. Hancox, Rui He, Sahaana Arumugam, Madison R. Mix, Aliasger K. Salem and John T. Harty
Nature microbiology, Vol.11(3), pp.718-730
03/2026
DOI: 10.1038/s41564-026-02263-0
PMCID: PMC12962968
PMID: 41629565
url
https://doi.org/10.1038/s41564-026-02263-0View
Published (Version of record) Open Access

Abstract

Immunization with radiation-attenuated sporozoites (RAS) drives effective sterilizing immunity against liver-stage Plasmodium infection. However, protection is compromised in individuals living in malaria endemic regions and the mechanisms of vaccine failure are unclear. Here we show that previous blood-stage exposure in a mouse model of Plasmodium yoelii infection compromises Plasmodium berghei RAS-induced essential CD8+ T cell responses and subsequent protection. The persisting malarial pigment haemozoin mediates impaired CD8+ T cell responses owing to impaired antigen uptake by dendritic cells, leading to reduced T cell activation. We designed a lipid nanoparticle-encapsulated mRNA vaccine that encodes a string of Plasmodium CD8+ T cell epitopes, which overcomes the defective T cell response and restores protection in Plasmodium-exposed mice. A combined RAS-plus-mRNA vaccine regimen enhances liver-resident memory T cells and protection in murine malaria-experienced hosts. The identification of haemozoin as a potential obstacle to vaccine efficacy in malaria endemic areas can inform the design of more effective malaria vaccines.
Microbiology Life Sciences & Biomedicine Science & Technology

Details

Metrics

1 Record Views
Logo image